In-Vitro IBD Diagnostic Market - Top Companies and Manufacturers

  • Report ID: 3414
  • Published Date: Oct 18, 2024
  • Report Format: PDF, PPT

Companies Dominating the In-Vitro Inflammatory Bowel Disease (IBD) Diagnostic Landscape

    Our report has covered detailed company profiling comprising company overview, business strategies, key product offerings, financial performance, key performance indicators, risk analysis, recent developments, regional presence, and SWOT analysis among other notable indicators for competitive positioning. Some of the prominent industry leaders in the in-vitro inflammatory bowel disease (IBD) diagnostic market that are included in our report are

    • DiaSorin S.p.A.,
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • American Laboratory Products Company, Ltd.
    • (d/b/a ALPCO Diagnostics),
    • Quidel Corporation,
    • CerTest Biotec, S.L.,
    • BUHLMANN Laboratories AG,
    • BioSystems S.A., Inova Diagnostics, Inc. (Werfen), and others.

Browse Key Market Insights with Data Illustration:

In the News

  • July 12, 2021: Quidel Corporation announced that it has received the CE Mark for two of its products, namely, Savanna multiplex molecular analyzer and Savanna RVP4 Assay (Respiratory Viral Panel-4). The Savanna system, which is an automated in-vitro diagnostic platform, can now be sold in the markets of Europe and other countries where the CE Mark is accepted.


Author Credits:  Radhika Pawar


  • Report ID: 3414
  • Published Date: Oct 18, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of in-vitro IBD diagnostic is assessed at USD 1.91 billion.

In-Vitro Inflammatory Bowel Disease (IBD) Diagnostic Market size was over USD 1.83 billion in 2023 and is projected to reach USD 3.58 billion by 2036, growing at around 5.3% CAGR during the forecast period i.e., between 2024-2036.

North America industry is estimated to account for largest revenue share of 44% by 2036

The major players in the market are are DiaSorin S.p.A., American Laboratory Products Company, Ltd. (d/b/a ALPCO Diagnostics), Quidel Corporation, CerTest Biotec, S.L., BUHLMANN Laboratories AG, and others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample